TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
EIKN

Eikon Therapeutics, Inc.

Healthcare · Biotechnology

7.90$ -4.5% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Eikon Therapeutics, Inc. (EIKN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 54.8% of the shares are freely tradable; institutional investors hold 69.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 69.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 17.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 54.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 13.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 54Mio.

Largest Shareholders

Institutions

Institutions EIKN
Name Stake (%) Shares Change (%) Date
FMR Inc 7.08 3,836,830 +0.0 03/31/2026
BlackRock Inc 6.13 3,319,379 +0.0 03/31/2026
Foresite Capital Management IV, LLC 3.59 1,943,682 +0.0 06/30/2026
Merck & Co Inc 3.08 1,666,666 +0.0 06/30/2026
Foresite Capital Management V, LLC 2.44 1,318,983 +0.0 06/30/2026
T. Rowe Price Investment Management,Inc. 2.26 1,222,487 +0.0 03/31/2026
Capital World Investors 2.17 1,175,944 +2.8 06/30/2026

Funds

Funds EIKN
Name Stake (%) Shares Change (%) Date
BGF World Healthscience A2 2.81 1,521,464 +0.0 05/31/2026
Fidelity Contrafund 2.35 1,274,701 -0.1 07/31/2026
Fidelity Select Biotechnology 2.13 1,152,933 +4.9 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings EIKN
Person Role Shares Value As of Type
Column Group IV GP, LP 10% Owner 89,200 704,680 $ Sep 3, 2026 indirect

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 3, 2026 Column Group IV GP, LP 10% Owner Buy 89,200 11.56 1,031,045

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?